Medical Manufacturing Technologies Acquires Comco
Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management and a leading global provider of automated, process-driven medical device manufacturing solutions, has announced the acquisition of Burbank-based Comco, a recognized leader in the micro-precision sandblasting sector. This strategic move is set to significantly enhance MMT's abrasive technology offerings while expanding its microblasting capabilities.
Established in 1965, Comco is a leading company in the microblasting space, a technique utilized for deburring, texturing, cleaning and modifying part surfaces. As the creators of the award-winning MicroBlaster, Comco has gained the trust of industry professionals in medical manufacturing, microelectronics, precision machining and aerospace, positioning itself as the premier partner for microblasting solutions.
Commenting on the acquisition, Robbie Atkinson, CEO of MMT, said, 'We are thrilled to expand our range of comprehensive manufacturing solutions with the acquisition of Comco. This new partnership will strengthen our position as a trusted end-to-end provider of medical and specialized industrial manufacturing services and solutions worldwide. Comco's commitment to quality products, exceptional customer support and outstanding technical assistance aligns perfectly with MMT's dedication to innovation and customer care, ultimately helping customers achieve success.'
Comco's MicroBlaster operates by uniformly mixing clean, dry air with abrasive particles as small as 17.5 microns. The mixture is propelled through a nozzle tip at high velocity, resulting in a tightly focused and easily controlled abrasive stream. This state-of-the-art technology enables consistent microblasting parameters, ensuring a high level of repeatability and providing a cost-effective, environmentally friendly manufacturing method.
'We're thrilled to announce our collaboration with MMT, a trusted leader in automated, process-driven manufacturing,' stated Colin Weightman, president of Comco. 'By combining our unique strengths and expertise, we are committed to delivering innovative solutions that will enhance the customer experience and propel the manufacturing industry towards new heights of success.'
Weightman will assume the role of technical sales director, contributing to the growth of MMT's abrasive technologies while also strengthening partnerships and promoting ongoing innovation in microblasting to solve manufacturing challenges.
Information was sourced from Businesswire. Learn more by contacting Leah.Davidson@mmt-inc.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Anna Wintour is hiring at Vogue. Here's how to thrive when your boss used to have your job.
Whomever replaces Anna Wintour in running day-to-day operations at American Vogue will have some enormous stilettos to fill. That's partly because Wintour, who's 75, has been at the job for nearly four decades and is a legend in the business. It's also because whoever comes next will report to her. Wintour, who became Vogue's editor in chief in 1988, is giving up that role. However, she'll remain global editorial director at the magazine and chief content officer for its parent company, Condé Nast, the company said Thursday. Taking on a senior role, similar to the one Wintour vacated at Vogue, is often challenging, especially when the predecessor remains on hand, leadership experts told Business Insider. Incoming leaders are wise to signal that they want to make changes without abandoning what makes an organization work, said Kevin Groves, a professor of management at Pepperdine's Graziadio Business School. "We're preserving what's most important to us, while recognizing our environment has changed," he said. Here are three pieces of advice on taking over after a leader who looms large — and who might still be down the hall. Don't be impatient Stepping into this position successfully starts with indicating sincere interest in the role and prioritizing what's best for the organization, Nancy Ho, an executive coach based in Singapore, told BI. "You cannot be impatient and rush into it. It should not be seen like you're power-hungry or claiming a role prematurely," Ho said. Instead, she said, new leaders need to focus on understanding a company's culture and how they can position themselves as an asset to the organization. James Reed, CEO of the UK-based recruitment company Reed, said there is no harm in declaring to your boss that you are ambitious and aim to lead an organization, "even if you avoid explicitly saying you're after their job." "Ask what you need to learn and what more you can contribute to support them," Reed said. "Then they will be aware of your ambition but appreciate that you are seeking to help and learn from them rather than undermine them." Don't rock the boat too early Ho said it's important not to make drastic changes too soon upon getting the job. Ho recommended that the first step is acknowledging the good work done before them. Then, they should gain the team's trust by carefully working with them and making small, gradual changes to improve the organization's effectiveness. "When there's a certain buy-in, and people are more comfortable with a different leader, then you introduce changes," she said. Sabina Nawaz, a US-based CEO coach, said new leaders should not make changes for at least the first three months because the first thing to do after receiving the title is "to be curious." "Go on a listening tour, excavate the reasons behind decisions or actions, try to make sense of things from the perspective of others: given that they're smart and well-meaning, what did they have in mind when they acted this way," Nawaz said. Christian Tröster, a professor of leadership and organizational behavior at Germany's Kühne Logistics University, told BI that new leaders can demonstrate they're becoming part of the organization by being careful not to suggest that everything should change. "Because then you're showing that you are not like them, that you cannot be trusted," Tröster said. "Then you don't have the commitment of your employees to actually go with you." Tröster said that when an incoming leader would have to report to the person who held the post in the past, it's important to have a conversation about expectations. He said that while org charts are often clear, layers are often not always evident, including what relationships people have and who they tend to go to for advice. "I would try to make that visible," Tröster said. That way, he said, workers know who they're expected to go to and leaders and employees can agree to the arrangement. Don't be afraid to be different For those taking over a new role while their predecessor is still around — especially someone as "established and admired" as Anna Wintour, it's important to take advantage of your access to them, Amanda Augustine, a career coach at told BI via email. "Start the job as a sponge, learning what you can from your predecessor and other colleagues," she said, adding that it's important not to stay in information-gathering mode forever. Jochen Menges, a professor of leadership at the University of Zurich and the University of Cambridge, told BI that new leaders should "be different" and avoid trying to replicate the exact leadership style or strategy of the person they're replacing. "If they're too close, then they'll seem to be a copy, and then they can never live up," he said. When new bosses are different in some ways, Menges said, they can be "a leader in their own right."
Business Insider
5 hours ago
- Business Insider
M&A News: Nvidia (NVDA) Acquires AI Startup CentML
Chipmaker Nvidia (NVDA) has acquired Toronto-based AI startup CentML, according to The Logic, which is a major win for the startup and its investors. Interestingly, LinkedIn profiles show that CentML CEO Gennady Pekhimenko has taken on a senior director role for AI software at Nvidia, while the startup's CTO and COO also joined in managerial positions. In total, at least 15 engineers and two interns from CentML have joined Nvidia this month, the report added. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter It is worth noting that CentML, founded in 2022, focused on helping companies run AI systems more efficiently by optimizing how models use hardware resources. The startup had raised about $30.9 million in venture capital, including a $27 million seed round that Nvidia participated in last year. CentML was also part of Nvidia's accelerator program and had already been collaborating with the tech giant before the acquisition. As a result of the move, the company will stop offering services by July 17, according to a message posted in CentML's Slack channel and on X. Unfortunately, not all CentML employees are making the move to Nvidia, as some roles were cut due to an 'organizational restructuring.' This included CentML dissolving its federal incorporation and re-registering under British Columbia law in early June. Meanwhile, Nvidia continues its upward momentum, with shares gaining nearly 17% year-to-date and rising again on Friday. With a market cap of about $3.78 trillion, analysts at Wedbush believe that Nvidia could hit $4 trillion this year and possibly reach $5 trillion within the next 18 months as the AI boom accelerates. What Is a Good Price for NVDA? Turning to Wall Street, analysts have a Strong Buy consensus rating on NVDA stock based on 35 Buys, four Holds, and one Sell assigned in the past three months, as indicated by the graphic below. Furthermore, the average NVDA price target of $175.28 per share implies 11.6% upside potential.
Business Upturn
7 hours ago
- Business Upturn
Sage Healthspan Launches AI-Powered, Privacy-First Wellness App to Bridge Critical Gaps in Preventative Healthcare
Orange County, California, June 27, 2025 (GLOBE NEWSWIRE) — Sage Healthspan, a California-based digital health company, announced its precision health app, now available for free on Apple's App Store. Designed to address notable shortcomings in modern healthcare delivery, Sage introduces a privacy-first, on-device artificial intelligence (AI) platform aimed at helping users interpret their blood work, monitor health trends, and optimize wellness without sacrificing data security. A Glimpse into Sage Healthspan Analytic Features In an era where preventative healthcare is increasingly prioritized, many individuals still lack access to timely, comprehensible, and actionable insights from their routine lab results. Sage Healthspan identified a persistent issue: although patients regularly undergo blood tests, most are only contacted if major abnormalities are flagged. This approach overlooks nuanced health patterns and early indicators of disease, leading to missed opportunities for early intervention. 'Instead of waiting for symptoms to appear, Sage empowers users to engage proactively with their health data,' said Megan Haas, Media and Communications Lead at Sage Healthspan. 'The AI platform helps transform routine lab work into structured insights, encouraging users to take control of their health trajectory in a secure, comprehensible, and private way.' Closing the Loop Between Data and Action Sage allows users to upload or photograph existing lab results directly from their Apple devices. The platform then interprets the data using local AI algorithms, never uploading personal information to the cloud, providing summaries, visualizations, and tailored recommendations. This includes suggestions for lifestyle adjustments, supplement considerations, or follow-up testing to support long-term wellness goals. Importantly, Sage differentiates itself by emphasizing a 'privacy-first' model. All health data remains on the user's device, enabling secure HIPAA-compliant analysis. In a climate where 78% of healthcare executives name cybersecurity as a top priority, Sage's on-device processing offers a practical alternative to cloud-based health apps. A Comprehensive Health Insight Engine Sage's AI generates insights across an extensive array of health and biomarker categories, including cardiometabolic health, inflammation, blood sugar, autoimmunity, nutrient status, thyroid health, kidney and liver function, and more. As users contribute additional data over time, Sage builds a personalized timeline, allowing for trend detection and wellness optimization rooted in longitudinal analysis. A unique feature of Sage's platform is its lab test ordering capability. Users can independently request advanced biomarkers that are often excluded from standard panels. These include cardiovascular indicators such as ApoB and Lp(a), fasting insulin and HOMA-IR for metabolic health, thyroid and sex hormone assessments, and nutritional markers like vitamin D and omega-3 fatty acid levels. The Growing Importance of Intelligent Health Analytics Recent studies show that 67% of patients report confusion over their lab results, with 61% struggling to understand medical terminology. Additionally, with primary care visits averaging only 15-18 minutes, providers have limited time to address complex, individualized wellness concerns. Sage Healthspan aims to complement, not replace, medical professionals by offering supportive tools that clarify and contextualize lab data for users. From a broader healthcare systems perspective, early detection is increasingly recognized as a critical cost-saver. Nearly 90% of the United States' annual $4.5 trillion healthcare expenditure is tied to chronic conditions. Sage's focus on biomarker-based early detection aligns with evolving industry goals: identifying risk before symptoms arise and enabling targeted, timely action. Positioning in the Era of Medicine 3.0 The emergence of AI in health represents a shift toward what experts call 'Medicine 3.0,' a paradigm that emphasizes prevention, personalization, and patient empowerment. Sage Healthspan embodies this transition. By integrating intelligent health analytics into everyday devices and eliminating the need for cloud computing, the company delivers accessible wellness insights while maintaining robust privacy protections. Sage Healthspan is currently available exclusively for iOS on Apple's App Store. Users are encouraged to begin by uploading pre-existing lab results to generate immediate health insights. For more information or to learn how Sage can support a wellness journey, visit About Sage Healthspan Sage Healthspan is a health technology company based in California focused on closing critical gaps in preventative healthcare. Through its privacy-first AI app, Sage empowers users to understand and act on their blood work, providing structured insights across a range of biomarkers to support health optimization and early detection. Sage's core mission is to make personalized wellness both accessible and secure. Sage Healthspan Logo Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
